Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Haloperidol receptor specificity

Giannini AJ, Nageotte C, Loiselle RH, Malone DA, Price WA. Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis DA-2 receptor specificity. J Toxicol Clin Toxicol 1984-1985 22(6) 573-9. [Pg.625]

With the introduction of chlorpromazine in 1952, there was a small revolution in psychiatry patients suffering from psychosis were able to be de-institutionalized. Chlorpromazine and other typical antipsychotics (e.g., haloperidol) demonstrate high in vitro binding affinities for the dopamine D2 receptor (D2). Specifically, their... [Pg.370]

Some first-generation agents, such as haloperidol, are rather specific for one subtype of dopamine receptor, D2. This suggests that some degree of both efficacy and side effects are associated with dopamine antagonism at this receptor. However, the situation is complex, as usual. There are five classes of dopamine receptors known Di through D5. To complicate matters further, several of these classes have subclasses. In total, there are at least 15 dopamine receptors. Which of these is important for relief of the symptoms of schizophrenia Which is responsible for movement disorders The answers to these questions are incomplete. We do have a few hints. [Pg.305]

There is another reason why medications exert multiple effects. For example, an antidepressant that very specifically promotes serotonin neurotransmission and has little or no interaction with other receptor types will still produce multiple effects. How can this be Remember that in different areas of the brain, a single neurotransmitter can assume very distinct roles. When an individual takes a medication that alters the activity of a particular neurotransmitter, it generally does so throughout the brain. Consequently, the dopamine receptor blocking effect of haloperidol (Haldol) reduces hallucinations and paranoia in one brain region but causes upper extremity stiffness through its action in another brain region. [Pg.31]

Drugs that are successful in treating the disease act as dopamine receptor blockers and are known as antipsychot-ics or neuroleptics (e.g. chlorpromazine, haloperidol). Antipsychotic drags reduce some of the symptoms, especially the delusions and hallucinations. A side-effect of the drugs is that they can result in symptoms similar to those seen in patients with Parkinson s disease. This is not surprising, since the hypothesis to explain Parkinson s disease is too low a concentration of dopamine in a specific area of the brain (see below). [Pg.320]

D2 receptor, albeit with different specificity. Older examples of dopamine antagonists are chlorpromazine, haloperidol and many derivatives of these prototype compounds. Newer antipsychotic drugs such as risperidone, olanzapine and quetiapine have retained this mechanism of action, although no longer exclusively. [Pg.127]

Dopamine is a major neurotransmitter which acts on multiple receptors. It can activate both a and 3 adrenoceptors in addition to acting on specific dopamine receptors. These are widely distributed throughout the CNS and are also present in the renal tubules and renal and mesentric blood vessels, and many dopaminergic drugs are used in the treatment of Parkinson s disease, psychiatric disorders, as antiemetics, and for renal protection. Neuroleptic drugs, such as haloperidol and droperidol, are dopamine receptor antagonists. [Pg.28]

Aryltriazenes can also be decomposed by hydrogen fluoride in organic solution after extraction from their aqueous mother phase. In this case, hydrogen fluoride can be used in small excess but the nature of the solvent is crucial for example, tetrahydrofuran gives complex mixtures, dichloromethane promotes radical reactions (dimerizations, reductions) and acetic acid favors triazene decomposition before fluorination. Aromatic and haloaromatic compounds seem to be the best solvents.283 Such a technique, especially suited for the rapid introduction of an 18F atom, has been employed to produce [ 8F]haloperidol (3), the specific receptors of which have been localized in the brain by positron emission transaxial tomography.298... [Pg.727]

Rothblat DS, Schneider JS (1997) Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum. Neurosci Lett 228 119-22 Roy-Byrne PP (2005) The GABA-benzodiazepine receptor complex structure, function, and role in anxiety. J Clin Psychiatry 66 Suppl 2 14-20... [Pg.335]

In recent years traditional neuroleptics, as exemplified by chlorpromazine, have been structurally modified to produce drugs with greater affinity for dopamine receptors while retaining some of their activity on other receptor systems (e.g. on alpha] adrenoceptors, 5-HT2 receptors and histamine] receptors). In the non-phenothiazine series, a high degree of specificity for the D2 receptors has been achieved with sulpiride and pimozide, with haloperidol showing antagonistic effects on the 5-HT2 and alpha] adrenoceptors in addition to its selectivity for D2 receptors. The czs-(Z) isomers of the thioxanthines are potent neuroleptics that, in addition to... [Pg.281]

Die specificity of the dopamine receptor was further studied with a series of dopaminergic antagonists of well known pharmacological activity. The 30-40% inhibitory effect of 10 nM dopamine was completely reversed by the addition of increasing concentrations of the potent neuroleptics (+)butaclamol (Kp = 1.5 nM) and (-)sulpiride (Kp = 0.5 nM) while their pharmacologically weak enantiomers (-)butaclamol and (+)sulpiride were 86 and 167 times less potent, respectively. The neuroleptics spiroperidol, thioproperazine, domperidone, haloperidol, fluphenazine and pimozide completely reversed the inhibitory effect of dopamine at low Kp values ranging from 0.02 to 0.8 nM (41). [Pg.60]

Beaudry, G., Langlois, M.C., Weppe, I., Rouillard, C. and Levesque, D. (2000) Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. Journal of Neurochemistry, 75, 1694-1702. [Pg.450]


See other pages where Haloperidol receptor specificity is mentioned: [Pg.412]    [Pg.414]    [Pg.166]    [Pg.29]    [Pg.439]    [Pg.877]    [Pg.26]    [Pg.157]    [Pg.131]    [Pg.269]    [Pg.278]    [Pg.280]    [Pg.125]    [Pg.260]    [Pg.426]    [Pg.134]    [Pg.165]    [Pg.174]    [Pg.320]    [Pg.325]    [Pg.329]    [Pg.331]    [Pg.339]    [Pg.402]    [Pg.350]    [Pg.54]    [Pg.652]    [Pg.250]    [Pg.250]    [Pg.250]    [Pg.18]    [Pg.39]    [Pg.179]    [Pg.143]    [Pg.144]    [Pg.671]    [Pg.22]   
See also in sourсe #XX -- [ Pg.647 ]




SEARCH



Haloperidol

Haloperidol specificity

Receptor specificity

© 2024 chempedia.info